Organon International

Organon International is one of the...

• Fortune 500 (#568);
• Russell 3000.

Organon International is a company listed under the stock ticker OGN (US).

Organon International has a direct presence in 2 countries.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 40 main executives

Most searched biographies at Organon International

• Kevin Ali, Chief Executive Officer and Director
• Philip Ozuah, Director
• Fatima De Vera, Director

Popular executive movements at Organon International

• Charlotte Owens has joined the company as Head of Medical Affairs and Outcomes Research  (posted on September 6 2023).
• Juan Ferreira has joined the company as Chief Medical Officer  (posted on September 6 2023).

Create your alert
to follow the executive moves at Organon International.

Organon International has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Organon International

• Press releases | Organon

Social media about Organon International

• Organon International on Wikipedia, Google News & Yahoo Finance
• Organon International on LinkedIn, Twitter & YouTube

Contact by email its executives including Kevin Ali

Call Organon International at +1 908...

View the org chart

Register to receive your alert

Report an error